English

Eligibility Myelodysplastic Syndromes (MDS) NCT00528983

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years or older.
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of low or int-1 risk mds
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1]
C3463824
low platelet count, and/or low hemoglobin, and/or rbc transfusion-dependent and/or platelet transfusion-dependent
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1,1]
C0032181
UMLS CUI [1,2]
C0518015
UMLS CUI [1,3]
C0014772
UMLS CUI [1,4]
C1695982
ecog performance status 0-2
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1]
C1520224
standard safety inclusion for serum creatinine, ast, alt, bilirubin.
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1,1]
C0600061
UMLS CUI [1,2]
C0201899
UMLS CUI [1,3]
C0201836
UMLS CUI [1,4]
C0005437
serum bicarbonate greater than or equal to 20 meq/l.
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1]
C0202059
use of acceptable birth control.
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1]
C0009862
signed, written informed consent.
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
diagnosis of acute pml.
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1]
C0023487
previous or concurrent malignancy.
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1]
C0006826
prior treatment with azacitidine or other demethylating agents.
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1]
C0004475
treatment with any anticancer therapy or investigational drugs within 21 days.
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0013230
hypersensitivity to azacitidine or mannitol.
Description

ID.13

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0004475
UMLS CUI [1,3]
C0024730
presence of gi disease.
Description

ID.14

Data type

boolean

Alias
UMLS CUI [1]
C0017178
active, uncontrolled infection.
Description

ID.15

Data type

boolean

Alias
UMLS CUI [1]
C3714514
known human immunodeficiency virus (hiv) or hepatitis c, or known active viral hepatitis b.
Description

ID.16

Data type

boolean

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0019196
UMLS CUI [1,3]
C0019163
breastfeeding or pregnant females;
Description

ID.17

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
presence of serious illness, medical condition, or other medical history which would be likely to interfere with a subject's participation in the study or with the interpretation of the results.
Description

ID.18

Data type

boolean

Alias
UMLS CUI [1]
C0012634
current congestive heart failure (ny heart association class iii-iv), unstable angina or angina requiring surgical or medical intervention within 6 months, myocardial infarct within 6 months, or uncontrolled cardiac arrhythmia.
Description

ID.19

Data type

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0002965
UMLS CUI [1,3]
C0027051
UMLS CUI [1,4]
C0003811
Back to the top of the page

Similar models

Eligibility Myelodysplastic Syndromes (MDS) NCT00528983

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
18 years or older.
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
diagnosis of low or int-1 risk mds
boolean
C3463824 (UMLS CUI [1])
ID.3
Item
low platelet count, and/or low hemoglobin, and/or rbc transfusion-dependent and/or platelet transfusion-dependent
boolean
C0032181 (UMLS CUI [1,1])
C0518015 (UMLS CUI [1,2])
C0014772 (UMLS CUI [1,3])
C1695982 (UMLS CUI [1,4])
ID.4
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
ID.5
Item
standard safety inclusion for serum creatinine, ast, alt, bilirubin.
boolean
C0600061 (UMLS CUI [1,1])
C0201899 (UMLS CUI [1,2])
C0201836 (UMLS CUI [1,3])
C0005437 (UMLS CUI [1,4])
ID.6
Item
serum bicarbonate greater than or equal to 20 meq/l.
boolean
C0202059 (UMLS CUI [1])
ID.7
Item
use of acceptable birth control.
boolean
C0009862 (UMLS CUI [1])
ID.8
Item
signed, written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.9
Item
diagnosis of acute pml.
boolean
C0023487 (UMLS CUI [1])
ID.10
Item
previous or concurrent malignancy.
boolean
C0006826 (UMLS CUI [1])
ID.11
Item
prior treatment with azacitidine or other demethylating agents.
boolean
C0004475 (UMLS CUI [1])
ID.12
Item
treatment with any anticancer therapy or investigational drugs within 21 days.
boolean
C0920425 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
ID.13
Item
hypersensitivity to azacitidine or mannitol.
boolean
C0020517 (UMLS CUI [1,1])
C0004475 (UMLS CUI [1,2])
C0024730 (UMLS CUI [1,3])
ID.14
Item
presence of gi disease.
boolean
C0017178 (UMLS CUI [1])
ID.15
Item
active, uncontrolled infection.
boolean
C3714514 (UMLS CUI [1])
ID.16
Item
known human immunodeficiency virus (hiv) or hepatitis c, or known active viral hepatitis b.
boolean
C0019682 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
C0019163 (UMLS CUI [1,3])
ID.17
Item
breastfeeding or pregnant females;
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.18
Item
presence of serious illness, medical condition, or other medical history which would be likely to interfere with a subject's participation in the study or with the interpretation of the results.
boolean
C0012634 (UMLS CUI [1])
ID.19
Item
current congestive heart failure (ny heart association class iii-iv), unstable angina or angina requiring surgical or medical intervention within 6 months, myocardial infarct within 6 months, or uncontrolled cardiac arrhythmia.
boolean
C0018802 (UMLS CUI [1,1])
C0002965 (UMLS CUI [1,2])
C0027051 (UMLS CUI [1,3])
C0003811 (UMLS CUI [1,4])
Back to the top of the page